Share on LinkedInShare on LinkedIn

ARTICLE · 15 DECEMBER 2025

Fed. Circ. Rulings Refine Patent Claim Construction Standards

In a series of decisions issued between March and August, the U.S. Court of Appeals for the Federal Circuit clarified several important principles governing patent claim construction.

United StatesLitigation, Mediation & Arbitration

In a series of decisions issued between March and August, the U.S. Court of Appeals for the Federal Circuit clarified several important principles governing patent claim construction.

These rulings — Maquet Cardiovascular LLC v. Abiomed Inc., Eye Therapies LLC v. Slayback Pharma LLC, FMC Corp. v. Sharda USA LLC and Acufloor LLC v. EvenTile Inc. — offer valuable insights into the role of prosecution history, transitional phrases and specification evolution in defining patent scope.

The cases clarify doctrinal standards and provide practical guidance for patent prosecutors and litigators. Below, we summarize each decision and highlight key litigation and prosecution practice tips.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from